Effect of diet on lipid profile in HIV-infected patients

被引:2
|
作者
Jackiewicz, Agata [1 ]
Czarnecki, Marcin [1 ]
Knysz, Brygida [1 ]
机构
[1] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immune Defic, 5 Koszarowa St, PL-51171 Wroclaw, Poland
来源
HIV & AIDS REVIEW | 2018年 / 17卷 / 03期
关键词
HIV; cardiovascular risk; lipid profile; diet therapy; antiretroviral therapy;
D O I
10.5114/hivar.2018.78484
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The implementation of highly active antiretroviral therapy has increased the life expectancy of people living with human immunodeficiency virus (HIV), thus reducing the number of deaths from acquired immune deficiency syndrome. Nowadays life expectancy of HIV(+) patients is comparable to those who are not infected. However, due to the use of antiretroviral therapy and the persistent immune activation and inflammation caused by HIV, other negative events may occur including dyslipidaemias, cardiovascular disorders, chronic kidney disease, early ageing, and neurocognitive impairment. It also increases the risk of developing metabolic syndrome and becomes a risk factor for cardiovascular disease: e.g. hypertension, brain stroke, and heart infarct. Comprehensive care of HIV patients with disturbed lipid profile includes lifestyle modifications such as dietary changes along with smoking cessation and has a beneficial effect on the lipid profile (total cholesterol, LDL, HDL, triglyceride levels). Therefore, it can reduce the risk of cardiovascular disease, allows the patients to avoid additional pharmacotherapy, and can eliminate drug-drug interactions with antiretroviral drugs. There are a lot of data showing that early dietary intervention and consistent diet control have a beneficial effect on lipid disorders in HIV-infected patients. Clinicians should be aware of it. In view of the benefits that can be gained by people living with HIV from dietary intervention, it is appropriate to include dieticians in a panel of specialists who take care of HIV(+) patients.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [41] Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients
    Jaruratanasirikul, S
    Sriwiriyajan, S
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (03) : 409 - 412
  • [42] Clinical and biological profile of newly diagnosed HIV-infected patients in Casablanca
    Lyazidi, S.
    Marih, L.
    El Filai, K. Marhoum
    Hassoune, S.
    Nani, S.
    Sodqi, M.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [43] HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients
    Kotler, Donald P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 : S79 - S85
  • [44] Psychopharmacology in HIV-infected patients
    Repetto, Martin J.
    Petitto, John M.
    PSYCHOSOMATIC MEDICINE, 2008, 70 (05): : 585 - 592
  • [45] Osteonecrosis in HIV-infected patients
    Bottaro, EG
    Figueroa, RH
    Scapellato, PG
    Vidal, GI
    Brieschke, MTR
    Da Representaçao, S
    Seoane, MB
    Laurido, MF
    Caiafa, D
    Lopardo, G
    Herrera, F
    Cassetti, I
    MEDICINA-BUENOS AIRES, 2004, 64 (04) : 325 - 331
  • [46] IMMUNOLOGICAL PROFILE IN HIV-INFECTED CHILDREN WITH HEMOPHILIA
    EBENER, U
    GUSSETIS, ES
    KREUZ, W
    WOLFF, H
    KRACKHARDT, B
    WEHNER, S
    KORNHUBER, B
    BLUT, 1987, 55 (04): : 301 - 301
  • [47] Thrombocytopenia in HIV-Infected Patients
    Francielle Garcia Nascimento
    Paula Yurie Tanaka
    Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 109 - 111
  • [48] Onychomycosis in HIV-infected patients
    Ravnborg, L
    Baastrup, N
    Svejgaard, E
    ACTA DERMATO-VENEREOLOGICA, 1998, 78 (02) : 151 - 152
  • [49] Hemoptysis in HIV-infected patients
    Nelson, JE
    Forman, M
    CHEST, 1996, 110 (03) : 737 - 743
  • [50] Radiotherapy for HIV-infected patients
    Quero, L.
    Gobert, A.
    Spano, J. -P.
    CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 496 - 501